A molecular chaperone glucose-regulated protein 94 blocks apoptosis induced by virus infection

Hepatology

Volumn 47, Issue 3, 2008, Pages 854-866

  Song, Hee Lee ^a   Song, Ran ^a   Mi, Nam Lee ^a   Chon, Saeng Kim ^a   Lee, Hanna ^b   Kong, Young Yun ^a   Kim, Hoguen ^b   Sung, Key Jang ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; FLICE INHIBITORY PROTEIN; GLUCOSE REGULATED PROTEIN 94; GLYCOPROTEIN E2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; SURVIVIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS; BIRC4 PROTEIN, HUMAN; BIRC5 PROTEIN, HUMAN; ENDOPLASMIN; GLYCOPROTEIN E2, HEPATITIS C VIRUS; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

APOPTOSIS; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INHIBITION KINETICS; LIVER; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ADULT; AGED; DRUG ANTAGONISM; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; TUMOR CELL LINE; VIROLOGY;

ADULT; AGED; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; HEPATITIS C; HUMANS; LIVER; MALE; MEMBRANE GLYCOPROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOLECULAR CHAPERONES; NEOPLASM PROTEINS; NF-KAPPA B; RNA, SMALL INTERFERING; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; VIRAL ENVELOPE PROTEINS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 40949097715     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22107     Document Type: Article

References (66)

1. Qureshi SA. Hepatitis C virus: biology, host evasion strategies, and promising new therapies on the horizon. Med Res Rev 2007;27:353-373.
2. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. HEPATOLOGY 1997;26(Suppl):15S-20S.
3. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. HEPATOLOGY 1991;14:969-974.
4. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-364.
5. Delic D, Nesic Z, Simonovic J, Svirtlih N, Dokic L, Neskovic G. [Chronic hepatitis C virus infection: is there a correlation between HCV genotypes and the level of vitemia?]. Med Ptegl 2006;59:230-234.
6. Nitkiewicz J. [Chronic hepatitis C infection-mechanisms of virus "immune escape"]. Przegl Epidemiol 2004;58:423-433.
7. Benedict CA, Norris PS, Ware CF. To kill or be killed: viral evasion of apoptosis. Nat Immunol 2002;3:1013-1018.
8. Rahman MM, McFadden G. Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathogens 2006;2:e4.
9. Munoz E, Israel A. Activation of NF-kappa B by the Tax protein of HTLV-1. Immunobiology 1995;193:128-136.
10. Hiscott J, Kwon H, Genin P. Hostile takeovers: viral appropriation of the NF-kappaB pathway. J Clin Invest 2001;107:143-151.
11. Shimotohno K. Hepatitis C virus and its pathogenesis. Semin Cancel Biol 2000;10:233-240.
12. Peng Z, Zhang Y, Gu W, Wang Z, Li D, Zhang F, et al. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Int J Oncol 2005;26:467-473.
13. Tai DI, Tsai SL, Chang YH, Huang SN, Chen TC, Chang KS, et al. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 2000;89:2274-2281.
14. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006;25:6680-6684.
15. Hiscott J, Nguyen TL, Arguello M, Nakhaei P, Paz S. Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses. Oncogene 2006;25:6844-6867.
16. Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev. 2004;18:2195-2224.
17. Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006;2006:re13.
18. Hiscott J, Nguyen TLA, Arguello M, Nakhaei P, Paz S. Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses. Oncogene 2006;25:6844-6867.
19. Karin M, Lin A. NF-κB at the crossroads of life and death. Nat Immunol 2002;3:221-227.
20. Liao QJ, Ye LB, Timani KA, Zeng YC, She YL, Ye L, et al. Activation of NF-kappaB by the full-length nucleocapsid protein of the SARS coronavirus. Acta Biochim Biophys Sin (Shanghai) 2005;37:607-612.
21. Caposio P, Dreano M, Garotta G, Gribaudo G, Landolfo S. Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication. J Virol 2004;78:3190-3195.
22. Patel A, Hanson J, McLean TI, Olgiate J, Hilton M, Miller WE, et al. Herpes simplex virus type 1 induction of persistent NF-κB nuclear translocation increases the efficiency of virus replication. Virology 1998;247:212-222.
23. Schwarz EM, Badorff C, Hiura TS, Wessely R, Badorff A, Verma IM, et al. NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice. J Virol 1998;72:5654-5660.
24. Goodkin ML, Ting AT, Blaho JA. NF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infection. J Virol 2003;77:7261-7280.
25. Lisowska K, Witkowski JM. Viral strategies in modulation of NF-kappaB activity. Arch Immunol Ther Exp (Warsz) 2003;51:367-375.
26. Mosialos G. The role of Rel/NF-kappa B proteins in viral oncogenesis and the regulation of viral transcription. Semin Cancer Biol 1997;8:121-129.
27. Eliopoulos AG, Caamano JH, Flavell J, Reynolds GM, Murray PG, Poyet JL, et al. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. Oncogene 2003;22:7557-7569.
28. Sorger PK, Pelham HR. The glucose-regulated protein grp94 is related to heat shock protein hsp90. J Mol Biol 1987;194:341-344.
29. Wearsch PA, Nicchitta CV. Purification and partial molecular characterization of GRP94, an ER resident chaperone. Protein Exp Purif 1996;7:114-121.
30. Nemoto TK, Ono T, Tanaka K. Substrate-binding characteristics of proteins in the 90 kDa heat shock protein family. Biochem J 2001;354:663-670.
31. Liao W, Li X, Mancini M, Chan L. Proteasome inhibition induces differential heat shock protein response but not unfolded protein response in HepG2 cells. J Cell Biochem 2006;99:1085-1095.
32. Marcu MG, Doyle M, Bertolotti A, Ron D, Hendershot L, Neckers L. Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha. Mol Cell Biol 2002;22:8506-8513.
33. Loo MA, Jensen TJ, Cui L, Hou Y, Chang XB, Riordan JR. Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. EMBO J 1998;17:6879-6887.
34. Argon Y, Simen BB. GRP94, an ER chaperone with protein and peptide binding properties. Semin Cell Dev Biol 1999;10:495-505.
35. Lee AS. Mammalian stress response: induction of the glucose-regulated protein family. Curr Opin Cell Biol 1992;4:267-273.
36. Lee AS. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci 2001;26:504-510.
37. Parmiani G, De Filippo A, Pilla L, Castelli C, Rivoltini L. Heat shock proteins gp96 as immunogens in cancer patients. Int J Hyperthermia 2006;22:223-227.
38. Miyagawa S, Soeda J, Takagi S, Miwa S, Ichikawa E, Noike T. Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer. Hum Pathol 2004;35:1392-1396.
39. Kovalchin JT, Murthy AS, Horattas MC, Guyton DP, Chandawarkar RY. Determinants of efficacy of immunotherapy with tumor-derived heat shock protein gp96. Cancer Immun 2001;1:7.
40. Reddy RK, Lu J, Lee AS. The endoplasmic reticulum chaperone glycoprotein GRP94 with Ca2+-binding and antiapoptotic properties is a novel proteolytic target of calpain during etoposide-induced apoptosis. J Biol Chem 1999;274:28476-28483.
41. Yao DF, Wu XH, Su XQ, Yao M, Wu W, Qiu LW, et al. Abnormal expression of HSP gp96 associated with HBV replication in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2006;5:381-386.
42. Zhu XD, Li CL, Lang ZW, Gao GF, Tien P. Significant correlation between expression level of HSP gp96 and progression of hepatitis B virus induced diseases. World J Gastroenterol 2004;10:1141-1145.
43. Meng SD, Gao T, Gao GF, Tien P. HBV-specific peptide associated with heat-shock protein gp96. Lancet 2001;357:528-529.
44. Neckers L. Using natural product inhibitors to validate Hsp90 as a molecular target in cancer. Curr Top Med Chem 2006;6:1163-1171.
45. Sharp S, Workman P, George F. Vande Woude aGK: inhibitors of the HSP90 molecular chaperone: Current status. In: Advances in cancer research. Vol 95. Academic Press, 2006:323-348.
46. Lee SH, Kim YK, Kim CS, Seol SK, Kim J, Cho S, et al. E2 of hepatitis C virus inhibits apoptosis. J Immunol 2005;175:8226-8235.
47. Hoshino T, Nakaya T, Araki W, Suzuki K, Suzuki T, Mizushima T. Endoplasmic reticulum chaperones inhibit the production of amyloid-beta peptides. Biochem J 2007;402:581-589.
48. Medici MA, Sciortino MT, Perri D, Amici C, Avitabile E, Ciotti M, et al. Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor κ B. J Biol Chem 2003;278:36059-36067.
49. Clarke P, Meintzer SM, Moffitt LA, Tyler KL. Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells. J Biol Chem 2003;278:18092-18100.
50. Liberman E, Fong Y-L, Selby MJ, Choo Q-L, Cousens L, Houghton M, et al. Activation of the grp78 and grp94 promoters by hepatitis c virus e2 envelope protein. J Virol 1999;73:3718-3722.
51. Benedict CA, Banks TA, Ware CF. Death and survival: viral regulation of TNF signaling pathways. Curr Opin Immunol 2003;15:59-65.
52. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005;11:791-796.
53. Kim CS, Jung JH, Wakita T, Yoon SK, Jang SK. Monitoring the antiviral effect of alpha interferon on individual cells. J Virol 2007;81:8814-8820.
54. Min N, Amy SL. ER chaperones in mammalian development and human diseases. FEBS Lett 2007;581:3641-3651.
55. Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006;2006:re13.
56. Yoshida H, Kato N, Shiratori Y, Otsuka M, Maeda S, Kato J, et al. Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor. J Biol Chem 2001;276:16399-16405.
57. Mann EA, Stanford S, Sherman KE. Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-κB activation. Virus Res 2006;121:51-57.
58. Joo M, Hahn YS, Kwon M, Sadikot RT, Blackwell TS, Christman JW. Hepatitis c virus core protein suppresses NF-κB activation and cyclooxygenase-2 expression by direct interaction with I κB kinase β. J Virol 2005;79:7648-7657.
59. Waris G, Livolsi A, Imbert V, Peyron J-F, Siddiqui A. Hepatitis C virus NS5A and subgenomic replicon activate NF-{kappa}B via tyrosine phosphorylation of I{kappa)B(alpha} and its degradation by calpain protease. J Biol Chem 2003;278:40778-40787.
60. Liao QJ, Ye LB, Timani KA, She YL, Yang XJ, Ye L, et al. Hepatitis C virus non-structural 5A protein can enhance full-length core protein-induced nuclear factor-kappaB activation. World J Gastroenterol 2005;11:6433-6439.
61. Morris JA, Dorner A, Edwards CA, Hendershot LM, Kaufman RJ. Immunoglobulin binding protein (BiP) function is required to protect cells from endoplasmic reticulum stress but is not required for the secretion of selective proteins. J Biol Chem 1997;272:4327-4334.
62. Pahl HL, Baeuerle PA. A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B. EMBO J 1995;14:2580-2588.
63. Chan S-W, Egan PA. Hepatitis C virus envelope proteins regulate CHOP via induction of the unfolded protein response. FASEB J 2005:04-3455fje.
64. Xu Z, Jensen G, Yen TS. Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. J Virol 1997;71:7387-7392.
65. Kamegaya Y, Hiasa Y, Zukerberg L, Fowler N, Blackard JT, Lin W, et al. Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. HEPATOLOGY 2005;41:660-667.
66. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005;10:86-103.